The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
The Madras High Court has recently allowed an appeal by Ab Initio Technology LLC, a US-based company, against the Patent ...
The Indian Patent Office's decision to cancel the patent for Novartis's major heart drug, Vymada, has added a new chapter to ...
The director of the United States Patent and Trademark Office (USPTO) has ordered a rare patent re-examination, after ...
KFF Health News on MSN
FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
Drug industry officials and analysts praised the FDA’s plans to streamline regulation of “biosimilars,” which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S ...
New policies rolled out by the U.S. patent office polices may make it harder for lower-cost medicines to reach consumers, ...
Bounding Into Comics on MSN
US Patent Office Director Orders “Reexamination” Of Nintendo Patent Of Sub-Character Summoning For Battle
The US Patent Office Director has ordered a reexamination of the Nintendo patent on summoning a sub-character to battle for ...
The patent world is at a moment of change. The incentives for obtaining and aggressively monetizing patents are increasing.
The head of the U.S. Patent Office is reexamining a decision to award Nintendo a patent that protects a common ...
The director of the U.S. patent office has pointed to examples of ‘prior art’ that might wreck Nintendo’s efforts to own certain mechanics related to summoning monsters ...
Donald Trump nominee and now USPTO head, John A. Squires, said there are "substantial new questions" about Nintendo's '397 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback